Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

NCT02824224 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Menorrhagia
Metrorrhagia
Medicated Intrauterine Devices

Interventions

DRUG: Tamoxifen
DRUG: Placebo (for Tamoxifen)

Sponsor

Oregon Health and Science University